PHILADELPHIA--(BUSINESS WIRE)--Lannett Company, Inc. (AMEX:LCI), a manufacturer of generic pharmaceuticals, today announced the closing of its previously announced underwritten registered public offering of 5,000,000 shares of its common stock. The company offered 2,500,000 shares of common stock and a selling stockholder of the company offered 2,500,000 shares of common stock. The net proceeds to Lannett from the sale of the shares, after the underwriting discounts and commissions and estimated offering expenses payable by Lannett, are expected to be approximately $11.4 million.
